» Articles » PMID: 2327771

Pharmacokinetics and Inflammatory Fluid Penetration of Cefpodoxime Proxetil in Volunteers

Overview
Specialty Pharmacology
Date 1990 Feb 1
PMID 2327771
Citations 15
Authors
Affiliations
Soon will be listed here.
Abstract

The pharmacokinetics of cefpodoxime were determined after a single oral dose of 261 mg of cefpodoxime proxetil, equivalent to 200 mg of cefpodoxime, was given to each of six healthy male volunteers. Concentrations in serum, urine, and cantharidin-induced inflammatory fluid were measured by a microbiological assay. The mean peak level in plasma was 2.1 micrograms/ml, attained at a mean time of 2.9 h. The mean half-life of elimination from serum was 2.2 h. The inflammatory exudate was penetrated moderately rapidly, the mean peak level being 1.7 micrograms/ml at 3.5 h. The mean percent penetration of the inflammatory exudate was 103.7. The mean 24-h urine recovery of cefpodoxime was 32.2%. This study suggests that cefpodoxime proxetil taken once or twice daily will be sufficient to treat urinary or systemic infections caused by susceptible pathogens.

Citing Articles

Cefazolin as a predictor of urinary cephalosporin activity in indicated Enterobacterales.

Bryson A, Bhalodi A, Liesman R, Mathers A J Clin Microbiol. 2024; 62(4):e0078821.

PMID: 38457194 PMC: 11005412. DOI: 10.1128/jcm.00788-21.


Pharmacokinetics and pharmacodynamics of newer oral cephalosporins: implications for treatment of community-acquired lower respiratory tract infections.

Cazzola M, Matera M, Donner C Clin Drug Investig. 2008; 16(4):335-46.

PMID: 18370555 DOI: 10.2165/00044011-199816040-00008.


Cefpodoxime proxetil: a review of its use in the management of bacterial infections in paediatric patients.

Fulton B, Perry C Paediatr Drugs. 2001; 3(2):137-58.

PMID: 11269640 DOI: 10.2165/00128072-200103020-00006.


Pharmacokinetics of cefetamet in plasma and skin blister fluid.

Zimmerli W, Sansano S, Wittke B Antimicrob Agents Chemother. 1996; 40(1):102-4.

PMID: 8787888 PMC: 163065. DOI: 10.1128/AAC.40.1.102.


Oral cephalosporins for use in a parenteral-to-oral switch programme.

Rimmer D Infection. 1995; 23 Suppl 2:S87-90.

PMID: 8537139 DOI: 10.1007/BF01742991.


References
1.
Bennett J, BRODIE J, BENNER E, KIRBY W . Simplified, accurate method for antibiotic assay of clinical specimens. Appl Microbiol. 1966; 14(2):170-7. PMC: 546645. DOI: 10.1128/am.14.2.170-177.1966. View

2.
Greenblatt D . Drug therapy. Clinical Pharmacokinetics (first of two parts). N Engl J Med. 1975; 293(14):702-5. DOI: 10.1056/NEJM197510022931406. View

3.
Wise R, Gillett A, Cadge B, Durham S, Baker S . The influence of protein binding upon tissue fluid levels of six beta-lactam antibiotics. J Infect Dis. 1980; 142(1):77-82. DOI: 10.1093/infdis/142.1.77. View

4.
Eng R, Gorski S, Person A, Mangura C, Chmel H . Clindamycin elimination in patients with liver disease. J Antimicrob Chemother. 1981; 8(4):277-81. DOI: 10.1093/jac/8.4.277. View

5.
Wise R, Andrews J . A comparison of the pharmacokinetics and tissue penetration of ceftriaxone, moxalactam and cefotaxime. Eur J Clin Microbiol. 1983; 2(5):505-8. DOI: 10.1007/BF02013917. View